Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/26 20:01 | 3/18/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Berkowitz Noah | CT | O | Chief Me | 2 | S | -139 | 11.47 | 0 | -12 | 203 | D | |||||||||||||||
3/2/26 20:57 | 2/27/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Houston John G | CT | D | 1 | S | -466 | 13.21 | 0 | -35 | 1,122 | D | ||||||||||||||||
2/25/26 17:09 | 2/23/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Loomis David K | CT | O | Chief Ac | 2 | S | -26 | 12.03 | 0 | -2 | 31 | D | |||||||||||||||
2/25/26 17:09 | 2/23/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Cacace Angela M | CT | O | Chief Sc | 2 | S | -98 | 12.01 | 0 | -8 | 151 | D | |||||||||||||||
2/25/26 17:08 | 2/23/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Teel Randy | CT | DO | P,CEO | 2 | S | -111 | 12.03 | 0 | -9 | 154 | D | |||||||||||||||
2/18/26 18:14 | 2/13/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Saik Andrew | CT | O | CFO | 1 | S | -61 | 11.89 | 0 | -5 | 159 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |